Tuberculosis Diagnosis and Treatment Market Size and Forecasts (2021 - 2031), Global and Regional Share, Trends, and Growth Opportunity Analysis

Coverage: Tuberculosis Diagnosis and Treatment Market covers analysis By Disease Type (Active TB, and Latent TB); Therapy (First-Line Therapy, and Second-Line Therapy); End Use (Clinics, Hospitals, Research Institutes and Academics, Reference Laboratories, and Others), and Geography (North America, Europe, Asia Pacific, and South and Central America)

Publication Month : Mar 2024

  • Report Code : TIPRE00022904
  • Category : Pharmaceuticals
  • Status : Upcoming
  • No. of Pages : 150
Inquire Before Buy

PRICING

$5190

$4671

MARKET OVERVIEW

Tuberculosis (TB) is a chronic disease and has become a global disease. Manufacturers of TB drugs are concerned with developing medications that can shorten the duration of treatment and help overcome the challenges of drug-susceptible TB and drug-resistant TB. TB treatment is divided into two types, such as first-line treatment, second-line treatment, and drug-resistant treatment. Advanced technologies and the introduction of novel therapies are expected to improve the duration of treating TB. However, most TB cases with currently available medicines can require up to 6 months of treatment. However, despite existing drugs and ongoing TB treatment drugs innovations, there is a continuous need to improve patients' access to appropriate TB medicines, particularly in the areas of multidrug-resistant TB (MDR TB) and pediatric TB.

MARKET SCOPE

The "Global Tuberculosis Diagnosis and Treatment Market Analysis to 2028" is a specialized and in-depth study of the pharmaceutical industry with a special focus on the global market trend analysis. The report aims to provide an overview of the tuberculosis diagnosis and treatment market with detailed market segmentation by disease type, therapy, end use, and geography. The report provides key statistics on the market status of the leading tuberculosis diagnosis and treatment market players and offers key trends and opportunities in the market.

MARKET SEGMENTATION

  •  Based on disease type, the global tuberculosis diagnosis and treatment market is segmented into active tb, latent tb.
  •  On the basis of therapy, the market is segmented into first-line therapy, second-line therapy.
  •  On the basis of end use, the market is segmented into clinics, hospitals, research institutes and academics, reference laboratories, others.

MARKET DYNAMICS
Drivers

  •  Rise in the incidences of drug susceptible tuberculosis.
  •  Advancements in testing kits technology.
  •  Increase research and development towards drug developments

Restraints

  •  The Second line treatment drugs are highly priced compared to first line treatment with more side effects and high level toxicity is the major restraining factor for this market.

REGIONAL FRAMEWORK

The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides an overview and forecast of the global market based on various segments. It also provides market size and forecast estimates from the year 2019 to 2028 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), the Middle East and Africa (MEA), and South America. The tuberculosis diagnosis and treatment market by each region is later sub-segmented by respective countries and segments. The report covers the analysis and forecast of 18 countries globally along with the current trend and opportunities prevailing in the region.

The report analyzes factors affecting the market from both demand and supply side and further evaluates market dynamics affecting the marketduring the forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA, and South America after evaluating political, economic, social and technological factors affecting the tuberculosis diagnosis and treatment market in these regions.

IMPACT OF COVID-19 ON TUBERCULOSIS DIAGNOSIS AND TREATMENT MARKET
COVID-19 first began in Wuhan (China) during December 2019 and since then it has spread at a fast pace across the globe. The US, India, Brazil, Russia, France, the UK, Turkey, Italy, and Spain are some of the worst affected countries in terms confirmed cases and reported deaths. The COVID-19 has been affecting economies and industries in various countries due to lockdowns, travel bans, and business shutdowns. Shutdown of various plants and factories has affected the global supply chains and negatively impacted the manufacturing, delivery schedules, and sales of products in global market. Few companies have already announced possible delays in product deliveries and slump in future sales of their products. In addition to this, the global travel bans imposed by countries in Europe, Asia-Pacific, and North America are affecting the business collaborations and partnerships opportunities.

World Geography

Have a question?

Analyst

Akshay

Akshay will walk you through a 15-minute call to present the report’s content and answer all queries if you have any.

Analyst   Speak to Analyst
  • Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
  • Request discounts available for Start-Ups & Universities
MARKET PLAYERS


The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides an overview and forecast of the global market based on various segments. It also provides market size and forecast estimates from the year 2019 to 2028 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), the Middle East and Africa (MEA), and South America. The tuberculosis diagnosis and treatment market by each region is later sub-segmented by respective countries and segments. The report covers the analysis and forecast of 18 countries globally along with the current trend and opportunities prevailing in the region.

The report analyzes factors affecting the market from both demand and supply side and further evaluates market dynamics affecting the marketduring the forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA, and South America after evaluating political, economic, social and technological factors affecting the tuberculosis diagnosis and treatment market in these regions.

IMPACT OF COVID-19 ON TUBERCULOSIS DIAGNOSIS AND TREATMENT MARKET
COVID-19 first began in Wuhan (China) during December 2019 and since then it has spread at a fast pace across the globe. The US, India, Brazil, Russia, France, the UK, Turkey, Italy, and Spain are some of the worst affected countries in terms confirmed cases and reported deaths. The COVID-19 has been affecting economies and industries in various countries due to lockdowns, travel bans, and business shutdowns. Shutdown of various plants and factories has affected the global supply chains and negatively impacted the manufacturing, delivery schedules, and sales of products in global market. Few companies have already announced possible delays in product deliveries and slump in future sales of their products. In addition to this, the global travel bans imposed by countries in Europe, Asia-Pacific, and North America are affecting the business collaborations and partnerships opportunities.

MARKET PLAYERS

The report covers key developments in the tuberculosis diagnosis and treatment market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies activities witnessed in the marketwere acquisitions, and partnership & collaborations. These activities have paved way for the expansion of business and customer base of market players. The market payers from tuberculosis diagnosis and treatment market are anticipated to lucrative growth opportunities in the future with the rising demand for tuberculosis diagnosis and treatment in the global market.

The report also includes the profiles of key companies along with their SWOT analysis and market strategies in the tuberculosis diagnosis and treatment market. In addition, the report focuses on leading industry players with information such as company profiles, components, and services offered, financial information of the last 3 years, the key development in the past five years.

  •  Medtronic
  •  St. Jude Medical (Abbott)
  •  Boston Scientific
  •  Cochlear
  •  Biotronik
  •  Sorin
  •  Abiomed
  •  MED-EL
  •  Nevro
  •  Sonova

The Insight Partner's dedicated research and analysis team consist of experienced professionals with advanced statistical expertise and offer various customization options in the existing study.
  • Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
  • Request discounts available for Start-Ups & Universities
Report Coverage
Report Coverage

Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends

Segment Covered
Segment Covered

This text is related
to segments covered.

Regional Scope
Regional Scope

North America, Europe, Asia Pacific, Middle East & Africa, South & Central America

Country Scope
Country Scope

This text is related
to country scope.

TABLE OF CONTENTS

1. INTRODUCTION
1.1. SCOPE OF THE STUDY
1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
1.3. MARKET SEGMENTATION
1.3.1 Tuberculosis Diagnosis And Treatment Market - By Disease Type
1.3.2 Tuberculosis Diagnosis And Treatment Market - By Therapy
1.3.3 Tuberculosis Diagnosis And Treatment Market - By End Use
1.3.4 Tuberculosis Diagnosis And Treatment Market - By Region
1.3.4.1 By Country
2. KEY TAKEAWAYS
3. RESEARCH METHODOLOGY
4. TUBERCULOSIS DIAGNOSIS AND TREATMENT MARKET LANDSCAPE
4.1. OVERVIEW
4.2. PEST ANALYSIS
4.2.1 North America - Pest Analysis
4.2.2 Europe - Pest Analysis
4.2.3 Asia-Pacific - Pest Analysis
4.2.4 Middle East and Africa - Pest Analysis
4.2.5 South and Central America - Pest Analysis
4.3. EXPERT OPINIONS
5. TUBERCULOSIS DIAGNOSIS AND TREATMENT MARKET - KEY MARKET DYNAMICS
5.1. KEY MARKET DRIVERS
5.2. KEY MARKET RESTRAINTS
5.3. KEY MARKET OPPORTUNITIES
5.4. FUTURE TRENDS
5.5. IMPACT ANALYSIS OF DRIVERS AND RESTRAINTS
6. TUBERCULOSIS DIAGNOSIS AND TREATMENT MARKET - GLOBAL MARKET ANALYSIS
6.1. TUBERCULOSIS DIAGNOSIS AND TREATMENT - GLOBAL MARKET OVERVIEW
6.2. TUBERCULOSIS DIAGNOSIS AND TREATMENT - GLOBAL MARKET AND FORECAST TO 2028
6.3. MARKET POSITIONING
7. TUBERCULOSIS DIAGNOSIS AND TREATMENT MARKET - REVENUE AND FORECASTS TO 2028 - DISEASE TYPE
7.1. OVERVIEW
7.2. DISEASE TYPE MARKET FORECASTS AND ANALYSIS
7.3. ACTIVE TB
7.3.1. Overview
7.3.2. Active TB Market Forecast and Analysis
7.4. LATENT TB
7.4.1. Overview
7.4.2. Latent TB Market Forecast and Analysis
8. TUBERCULOSIS DIAGNOSIS AND TREATMENT MARKET - REVENUE AND FORECASTS TO 2028 - THERAPY
8.1. OVERVIEW
8.2. THERAPY MARKET FORECASTS AND ANALYSIS
8.3. FIRST-LINE THERAPY
8.3.1. Overview
8.3.2. First-Line Therapy Market Forecast and Analysis
8.4. SECOND-LINE THERAPY
8.4.1. Overview
8.4.2. Second-Line Therapy Market Forecast and Analysis
9. TUBERCULOSIS DIAGNOSIS AND TREATMENT MARKET - REVENUE AND FORECASTS TO 2028 - END USE
9.1. OVERVIEW
9.2. END USE MARKET FORECASTS AND ANALYSIS
9.3. CLINICS
9.3.1. Overview
9.3.2. Clinics Market Forecast and Analysis
9.4. HOSPITALS
9.4.1. Overview
9.4.2. Hospitals Market Forecast and Analysis
9.5. RESEARCH INSTITUTES AND ACADEMICS
9.5.1. Overview
9.5.2. Research Institutes and Academics Market Forecast and Analysis
9.6. REFERENCE LABORATORIES
9.6.1. Overview
9.6.2. Reference Laboratories Market Forecast and Analysis
9.7. OTHERS
9.7.1. Overview
9.7.2. Others Market Forecast and Analysis
10. TUBERCULOSIS DIAGNOSIS AND TREATMENT MARKET REVENUE AND FORECASTS TO 2028 - GEOGRAPHICAL ANALYSIS
10.1. NORTH AMERICA
10.1.1 North America Tuberculosis Diagnosis And Treatment Market Overview
10.1.2 North America Tuberculosis Diagnosis And Treatment Market Forecasts and Analysis
10.1.3 North America Tuberculosis Diagnosis And Treatment Market Forecasts and Analysis - By Disease Type
10.1.4 North America Tuberculosis Diagnosis And Treatment Market Forecasts and Analysis - By Therapy
10.1.5 North America Tuberculosis Diagnosis And Treatment Market Forecasts and Analysis - By End Use
10.1.6 North America Tuberculosis Diagnosis And Treatment Market Forecasts and Analysis - By Countries
10.1.6.1 United States Tuberculosis Diagnosis And Treatment Market
10.1.6.1.1 United States Tuberculosis Diagnosis And Treatment Market by Disease Type
10.1.6.1.2 United States Tuberculosis Diagnosis And Treatment Market by Therapy
10.1.6.1.3 United States Tuberculosis Diagnosis And Treatment Market by End Use
10.1.6.2 Canada Tuberculosis Diagnosis And Treatment Market
10.1.6.2.1 Canada Tuberculosis Diagnosis And Treatment Market by Disease Type
10.1.6.2.2 Canada Tuberculosis Diagnosis And Treatment Market by Therapy
10.1.6.2.3 Canada Tuberculosis Diagnosis And Treatment Market by End Use
10.1.6.3 Mexico Tuberculosis Diagnosis And Treatment Market
10.1.6.3.1 Mexico Tuberculosis Diagnosis And Treatment Market by Disease Type
10.1.6.3.2 Mexico Tuberculosis Diagnosis And Treatment Market by Therapy
10.1.6.3.3 Mexico Tuberculosis Diagnosis And Treatment Market by End Use
10.2. EUROPE
10.2.1 Europe Tuberculosis Diagnosis And Treatment Market Overview
10.2.2 Europe Tuberculosis Diagnosis And Treatment Market Forecasts and Analysis
10.2.3 Europe Tuberculosis Diagnosis And Treatment Market Forecasts and Analysis - By Disease Type
10.2.4 Europe Tuberculosis Diagnosis And Treatment Market Forecasts and Analysis - By Therapy
10.2.5 Europe Tuberculosis Diagnosis And Treatment Market Forecasts and Analysis - By End Use
10.2.6 Europe Tuberculosis Diagnosis And Treatment Market Forecasts and Analysis - By Countries
10.2.6.1 Germany Tuberculosis Diagnosis And Treatment Market
10.2.6.1.1 Germany Tuberculosis Diagnosis And Treatment Market by Disease Type
10.2.6.1.2 Germany Tuberculosis Diagnosis And Treatment Market by Therapy
10.2.6.1.3 Germany Tuberculosis Diagnosis And Treatment Market by End Use
10.2.6.2 France Tuberculosis Diagnosis And Treatment Market
10.2.6.2.1 France Tuberculosis Diagnosis And Treatment Market by Disease Type
10.2.6.2.2 France Tuberculosis Diagnosis And Treatment Market by Therapy
10.2.6.2.3 France Tuberculosis Diagnosis And Treatment Market by End Use
10.2.6.3 Italy Tuberculosis Diagnosis And Treatment Market
10.2.6.3.1 Italy Tuberculosis Diagnosis And Treatment Market by Disease Type
10.2.6.3.2 Italy Tuberculosis Diagnosis And Treatment Market by Therapy
10.2.6.3.3 Italy Tuberculosis Diagnosis And Treatment Market by End Use
10.2.6.4 Spain Tuberculosis Diagnosis And Treatment Market
10.2.6.4.1 Spain Tuberculosis Diagnosis And Treatment Market by Disease Type
10.2.6.4.2 Spain Tuberculosis Diagnosis And Treatment Market by Therapy
10.2.6.4.3 Spain Tuberculosis Diagnosis And Treatment Market by End Use
10.2.6.5 United Kingdom Tuberculosis Diagnosis And Treatment Market
10.2.6.5.1 United Kingdom Tuberculosis Diagnosis And Treatment Market by Disease Type
10.2.6.5.2 United Kingdom Tuberculosis Diagnosis And Treatment Market by Therapy
10.2.6.5.3 United Kingdom Tuberculosis Diagnosis And Treatment Market by End Use
10.2.6.6 Rest of Europe Tuberculosis Diagnosis And Treatment Market
10.2.6.6.1 Rest of Europe Tuberculosis Diagnosis And Treatment Market by Disease Type
10.2.6.6.2 Rest of Europe Tuberculosis Diagnosis And Treatment Market by Therapy
10.2.6.6.3 Rest of Europe Tuberculosis Diagnosis And Treatment Market by End Use
10.3. ASIA-PACIFIC
10.3.1 Asia-Pacific Tuberculosis Diagnosis And Treatment Market Overview
10.3.2 Asia-Pacific Tuberculosis Diagnosis And Treatment Market Forecasts and Analysis
10.3.3 Asia-Pacific Tuberculosis Diagnosis And Treatment Market Forecasts and Analysis - By Disease Type
10.3.4 Asia-Pacific Tuberculosis Diagnosis And Treatment Market Forecasts and Analysis - By Therapy
10.3.5 Asia-Pacific Tuberculosis Diagnosis And Treatment Market Forecasts and Analysis - By End Use
10.3.6 Asia-Pacific Tuberculosis Diagnosis And Treatment Market Forecasts and Analysis - By Countries
10.3.6.1 Australia Tuberculosis Diagnosis And Treatment Market
10.3.6.1.1 Australia Tuberculosis Diagnosis And Treatment Market by Disease Type
10.3.6.1.2 Australia Tuberculosis Diagnosis And Treatment Market by Therapy
10.3.6.1.3 Australia Tuberculosis Diagnosis And Treatment Market by End Use
10.3.6.2 China Tuberculosis Diagnosis And Treatment Market
10.3.6.2.1 China Tuberculosis Diagnosis And Treatment Market by Disease Type
10.3.6.2.2 China Tuberculosis Diagnosis And Treatment Market by Therapy
10.3.6.2.3 China Tuberculosis Diagnosis And Treatment Market by End Use
10.3.6.3 India Tuberculosis Diagnosis And Treatment Market
10.3.6.3.1 India Tuberculosis Diagnosis And Treatment Market by Disease Type
10.3.6.3.2 India Tuberculosis Diagnosis And Treatment Market by Therapy
10.3.6.3.3 India Tuberculosis Diagnosis And Treatment Market by End Use
10.3.6.4 Japan Tuberculosis Diagnosis And Treatment Market
10.3.6.4.1 Japan Tuberculosis Diagnosis And Treatment Market by Disease Type
10.3.6.4.2 Japan Tuberculosis Diagnosis And Treatment Market by Therapy
10.3.6.4.3 Japan Tuberculosis Diagnosis And Treatment Market by End Use
10.3.6.5 South Korea Tuberculosis Diagnosis And Treatment Market
10.3.6.5.1 South Korea Tuberculosis Diagnosis And Treatment Market by Disease Type
10.3.6.5.2 South Korea Tuberculosis Diagnosis And Treatment Market by Therapy
10.3.6.5.3 South Korea Tuberculosis Diagnosis And Treatment Market by End Use
10.3.6.6 Rest of Asia-Pacific Tuberculosis Diagnosis And Treatment Market
10.3.6.6.1 Rest of Asia-Pacific Tuberculosis Diagnosis And Treatment Market by Disease Type
10.3.6.6.2 Rest of Asia-Pacific Tuberculosis Diagnosis And Treatment Market by Therapy
10.3.6.6.3 Rest of Asia-Pacific Tuberculosis Diagnosis And Treatment Market by End Use
10.4. MIDDLE EAST AND AFRICA
10.4.1 Middle East and Africa Tuberculosis Diagnosis And Treatment Market Overview
10.4.2 Middle East and Africa Tuberculosis Diagnosis And Treatment Market Forecasts and Analysis
10.4.3 Middle East and Africa Tuberculosis Diagnosis And Treatment Market Forecasts and Analysis - By Disease Type
10.4.4 Middle East and Africa Tuberculosis Diagnosis And Treatment Market Forecasts and Analysis - By Therapy
10.4.5 Middle East and Africa Tuberculosis Diagnosis And Treatment Market Forecasts and Analysis - By End Use
10.4.6 Middle East and Africa Tuberculosis Diagnosis And Treatment Market Forecasts and Analysis - By Countries
10.4.6.1 South Africa Tuberculosis Diagnosis And Treatment Market
10.4.6.1.1 South Africa Tuberculosis Diagnosis And Treatment Market by Disease Type
10.4.6.1.2 South Africa Tuberculosis Diagnosis And Treatment Market by Therapy
10.4.6.1.3 South Africa Tuberculosis Diagnosis And Treatment Market by End Use
10.4.6.2 Saudi Arabia Tuberculosis Diagnosis And Treatment Market
10.4.6.2.1 Saudi Arabia Tuberculosis Diagnosis And Treatment Market by Disease Type
10.4.6.2.2 Saudi Arabia Tuberculosis Diagnosis And Treatment Market by Therapy
10.4.6.2.3 Saudi Arabia Tuberculosis Diagnosis And Treatment Market by End Use
10.4.6.3 U.A.E Tuberculosis Diagnosis And Treatment Market
10.4.6.3.1 U.A.E Tuberculosis Diagnosis And Treatment Market by Disease Type
10.4.6.3.2 U.A.E Tuberculosis Diagnosis And Treatment Market by Therapy
10.4.6.3.3 U.A.E Tuberculosis Diagnosis And Treatment Market by End Use
10.4.6.4 Rest of Middle East and Africa Tuberculosis Diagnosis And Treatment Market
10.4.6.4.1 Rest of Middle East and Africa Tuberculosis Diagnosis And Treatment Market by Disease Type
10.4.6.4.2 Rest of Middle East and Africa Tuberculosis Diagnosis And Treatment Market by Therapy
10.4.6.4.3 Rest of Middle East and Africa Tuberculosis Diagnosis And Treatment Market by End Use
10.5. SOUTH AND CENTRAL AMERICA
10.5.1 South and Central America Tuberculosis Diagnosis And Treatment Market Overview
10.5.2 South and Central America Tuberculosis Diagnosis And Treatment Market Forecasts and Analysis
10.5.3 South and Central America Tuberculosis Diagnosis And Treatment Market Forecasts and Analysis - By Disease Type
10.5.4 South and Central America Tuberculosis Diagnosis And Treatment Market Forecasts and Analysis - By Therapy
10.5.5 South and Central America Tuberculosis Diagnosis And Treatment Market Forecasts and Analysis - By End Use
10.5.6 South and Central America Tuberculosis Diagnosis And Treatment Market Forecasts and Analysis - By Countries
10.5.6.1 Brazil Tuberculosis Diagnosis And Treatment Market
10.5.6.1.1 Brazil Tuberculosis Diagnosis And Treatment Market by Disease Type
10.5.6.1.2 Brazil Tuberculosis Diagnosis And Treatment Market by Therapy
10.5.6.1.3 Brazil Tuberculosis Diagnosis And Treatment Market by End Use
10.5.6.2 Argentina Tuberculosis Diagnosis And Treatment Market
10.5.6.2.1 Argentina Tuberculosis Diagnosis And Treatment Market by Disease Type
10.5.6.2.2 Argentina Tuberculosis Diagnosis And Treatment Market by Therapy
10.5.6.2.3 Argentina Tuberculosis Diagnosis And Treatment Market by End Use
10.5.6.3 Rest of South and Central America Tuberculosis Diagnosis And Treatment Market
10.5.6.3.1 Rest of South and Central America Tuberculosis Diagnosis And Treatment Market by Disease Type
10.5.6.3.2 Rest of South and Central America Tuberculosis Diagnosis And Treatment Market by Therapy
10.5.6.3.3 Rest of South and Central America Tuberculosis Diagnosis And Treatment Market by End Use
11. IMPACT OF COVID-19 PANDEMIC ON GLOBAL TUBERCULOSIS DIAGNOSIS AND TREATMENT MARKET
11.1 North America
11.2 Europe
11.3 Asia-Pacific
11.4 Middle East and Africa
11.5 South and Central America
12. INDUSTRY LANDSCAPE
12.1. MERGERS AND ACQUISITIONS
12.2. AGREEMENTS, COLLABORATIONS AND JOIN VENTURES
12.3. NEW PRODUCT LAUNCHES
12.4. EXPANSIONS AND OTHER STRATEGIC DEVELOPMENTS
13. TUBERCULOSIS DIAGNOSIS AND TREATMENT MARKET, KEY COMPANY PROFILES
13.1. ABBOTT LABORATORIES INC.
13.1.1. Key Facts
13.1.2. Business Description
13.1.3. Products and Services
13.1.4. Financial Overview
13.1.5. SWOT Analysis
13.1.6. Key Developments
13.2. AKONNI BIOSYSTEMS, INC
13.2.1. Key Facts
13.2.2. Business Description
13.2.3. Products and Services
13.2.4. Financial Overview
13.2.5. SWOT Analysis
13.2.6. Key Developments
13.3. ALERE, INC.
13.3.1. Key Facts
13.3.2. Business Description
13.3.3. Products and Services
13.3.4. Financial Overview
13.3.5. SWOT Analysis
13.3.6. Key Developments
13.4. BECTON DICKINSON AND CO.
13.4.1. Key Facts
13.4.2. Business Description
13.4.3. Products and Services
13.4.4. Financial Overview
13.4.5. SWOT Analysis
13.4.6. Key Developments
13.5. BIOCHEMICAL AND SYNTHETIC PRODUCTS PVT LTD
13.5.1. Key Facts
13.5.2. Business Description
13.5.3. Products and Services
13.5.4. Financial Overview
13.5.5. SWOT Analysis
13.5.6. Key Developments
13.6. BIOMéRIEUX SA
13.6.1. Key Facts
13.6.2. Business Description
13.6.3. Products and Services
13.6.4. Financial Overview
13.6.5. SWOT Analysis
13.6.6. Key Developments
13.7. CEPHEID INC.
13.7.1. Key Facts
13.7.2. Business Description
13.7.3. Products and Services
13.7.4. Financial Overview
13.7.5. SWOT Analysis
13.7.6. Key Developments
13.8. EIKEN CHEMICAL CO. LTD.
13.8.1. Key Facts
13.8.2. Business Description
13.8.3. Products and Services
13.8.4. Financial Overview
13.8.5. SWOT Analysis
13.8.6. Key Developments
13.9. EPISTEMLTD.
13.9.1. Key Facts
13.9.2. Business Description
13.9.3. Products and Services
13.9.4. Financial Overview
13.9.5. SWOT Analysis
13.9.6. Key Developments
13.10. F. HOFFMANN-LA ROCHE AG
13.10.1. Key Facts
13.10.2. Business Description
13.10.3. Products and Services
13.10.4. Financial Overview
13.10.5. SWOT Analysis
13.10.6. Key Developments
14. APPENDIX
14.1. ABOUT THE INSIGHT PARTNERS
14.2. GLOSSARY OF TERMS


* Above given report scope is tentative, and may change during the study process as per the research requirement.
* List of companies provided under ‘Company Profile’ chapter is tentative and may change during the course of the study. This list is customizable as per the client requirements.
* Financial information would be provided only for the public comp
The List of Companies

1. Abbott Laboratories Inc.
2. Akonni Biosystems, Inc.
3. Alere, Inc.
4. Becton Dickinson and Co.
5. Biochemical and Synthetic Products Pvt Ltd
6. Biomérieux SA
7. Cepheid Inc.
8. Eiken Chemical Co. Ltd.
9. EpistemLtd.
10. F. Hoffmann-LA Roche AG
11. GlaxoSmithKline PLC
12. Hain Lifescience GmbH
13. HologicInc.
14. Johnson & Johnson Services, Inc.
15. LabatecPharma SA
16. Lupin Pharmaceuticals Inc.
17. Novartis AG
18. Otsuka Pharmaceutical Co. Ltd.
19. PerkinElmer Inc.
20. Lupin Pharmaceuticals Inc

The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.

  1. Data Collection and Secondary Research:

As a market research and consulting firm operating from a decade, we have published many reports and advised several clients across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.

Several associations trade associates, technical forums, institutes, societies and organizations are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in the last 3 years are scrutinized and analyzed to understand the current market trends.

  1. Primary Research:

The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.

For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/Sales Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.

A typical research interview fulfils the following functions:

  • Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
  • Validates and strengthens in-house secondary research findings
  • Develops the analysis team’s expertise and market understanding

Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:

  • Industry participants: VPs, business development managers, market intelligence managers and national sales managers
  • Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.

Below is the breakup of our primary respondents by company, designation, and region:

Research Methodology

Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.

  1. Data Analysis:

Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.

  • 3.1 Macro-Economic Factor Analysis:

We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.

  • 3.2 Country Level Data:

Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.

  • 3.3 Company Profile:

The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.

  • 3.4 Developing Base Number:

Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.

  1. Data Triangulation and Final Review:

The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.

We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.

We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.

Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Trends and growth analysis reports related to Tuberculosis Diagnosis and Treatment Market